Physician profile
Ann E Wieman
NPI 1366557290
$1,729.06
in general payments reported to CMS, 2019-2025
13 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.62 · 2020: $76.95 · 2021: $82.16 · 2022: $547 · 2023: $407 · 2024: $308 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,181.15 | 2019-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Kerecis Limited | $115.00 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Koya Medical, INC. | $100.91 | 2025 | Dayspring, Koya Medical |
| Bioventus LLC | $48.39 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Zimvie INC. | $45.14 | 2022-2023 | |
| Ets Wound Care LLC | $44.76 | 2024 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $42.75 | 2019 | |
| Integra Lifesciences Corporation | $37.90 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $34.85 | 2024 | Intellis Adaptivestim |
| Tactile Systems Technology INC | $34.31 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Paragon 28, INC. | $18.99 | 2021 | |
| Lifenet Health | $13.20 | 2025 | Theragenesis Wound Matrix |
| Misonix INC | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Wieman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.